Keynote Prof Catherine Bollard
Senior Vice President, Children’s National Hospital
Dr. Catherine Bollard is the Senior Vice President & Chief Research Officer and the Dr. Robert J. and Florence T. Bosworth Distinguished Professor of Cancer and Transplantation Biology Research and the Director of the Center for Cancer and Immunology Research at Children’s National in Washington DC. She is also a Professor of Pediatrics and of Microbiology, Immunology, and Tropical Medicine at The George Washington University and the Associate Center Director for Translational Research and Innovation at the GW Cancer Center. Dr Bollard is a member of the American Society for Clinical Investigation and member of the Association of American Physicians (AAP). She is a past president of the International Society for Cellular Therapy (ISCT), and the current President of the Foundation for the Accreditation of Cellular Therapy (FACT). She is currently Editor in Chief of Blood Advances. Dr Bollard has >250 peer reviewed publications and has been independently NIH funded for over 15 years. Her bench and translational research focuses on improving outcomes for patients after transplant and on the development of novel cell therapies for cancer and virus-associated diseases.
Keynote Prof Catherine Bollard
Senior Vice President, Children’s National Hospital
Dr. Catherine Bollard is the Senior Vice President & Chief Research Officer and the Dr. Robert J. and Florence T. Bosworth Distinguished Professor of Cancer and Transplantation Biology Research and the Director of the Center for Cancer and Immunology Research at Children’s National in Washington DC. She is also a Professor of Pediatrics and of Microbiology, Immunology, and Tropical Medicine at The George Washington University and the Associate Center Director for Translational Research and Innovation at the GW Cancer Center. Dr Bollard is a member of the American Society for Clinical Investigation and member of the Association of American Physicians (AAP). She is a past president of the International Society for Cellular Therapy (ISCT), and the current President of the Foundation for the Accreditation of Cellular Therapy (FACT). She is currently Editor in Chief of Blood Advances. Dr Bollard has >250 peer reviewed publications and has been independently NIH funded for over 15 years. Her bench and translational research focuses on improving outcomes for patients after transplant and on the development of novel cell therapies for cancer and virus-associated diseases.